Form 4: Teladoc Health Executive Acquires 40,800 Restricted Stock Units

Arnnon Geshuri, Chief People Officer of Teladoc Health, recently acquired 40,800 restricted stock units (RSUs) representing a contingent right to receive one share of TDOC common stock.

Summary

• On March 19, 2024, Arnnon Geshuri, the Chief People Officer of Teladoc Health, acquired 40,800 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of Teladoc Health common stock.
• The RSUs vest over time, with one-third vesting on the first anniversary of the grant date.
• The remaining RSUs vest in eight substantially equal quarterly installments beginning on June 1, 2025.
• Following the transaction, Geshuri directly owns 40,800 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs by a key executive is generally a positive sign, indicating confidence in the company's future. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The acquisition of RSUs by a key executive demonstrates confidence in the company's future performance.

Future Outlook

The vesting schedule of the RSUs suggests a long-term commitment by the executive to the company's success.

Industry Context

Executive compensation in the form of stock options and RSUs is a common practice in the healthcare technology industry to align management's interests with those of shareholders.

Comparison to Industry Standards

• Stock-based compensation is a standard practice among publicly traded companies, particularly in the tech and healthcare sectors.
• Companies like Amwell and Accolade also utilize RSUs as part of their executive compensation packages.
• The vesting schedule described is typical, aligning with industry norms for incentivizing long-term performance.

Stakeholder Impact

• The acquisition of RSUs by a key executive can positively influence shareholder sentiment.
• The vesting schedule incentivizes the executive to contribute to the company's long-term success, benefiting shareholders.

Key Dates